Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Neurodevelopment disorders and genetic testing: current approaches and future advances.Ann Neurol. 2013; 72 (Available at:): 164-170
- Diagnostic and statistical manual of mental disorders: diagnostic and statistical manual of mental disorders.5th edition. American Psychiatric Association, Arlington (VA)2013
- Clinical characteristics of intellectual disabilities. Mental disorders and disabilities among low-income children.The National Academic Press, Washington, DC2015
- Autism spectrum disorder: classification, diagnosis and therapy.Pharmacol Ther. 2018; 190 (Available at:): 91-104
- From Kanner to DSM-5: autism as an evolving diagnostic concept.Annu Rev Clin Psychol. 2014; 10 (Available at:): 193-212
- The co-occurrence of epilepsy and autism: a systematic review.Epilepsy Behav. 2019; 98 (Available at:): 238-248
- CDC website.(Available at:) (Accessed November 23, 2019)
- The diagnostic yield of array comparative genomic hybridization is high regardless of severity of intellectual disability/developmental delay in children.J Child Neurol. 2016; 31 (Available at:): 691-699
- Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.Am J Hum Genet. 2010; 86 (Available at:): 749-764
- Updates in the genetic evaluation of the child with global developmental delay or intellectual disability.Semin Pediatr Neurol. 2012; 19 (Available at:): 173-180
- Practice parameter: evaluation of the child with global developmental delay: report of the quality standards subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society.Neurology. 2003; 60 (Available at:): 367-380
- Fading competency of cytogenetic diagnostic laboratories: the alarm bell has started to ring.Eur J Hum Genet. 2017; 25 (Available at:): 273-274
- The utility of chromosomal microarray analysis in developmental and behavioral pediatrics.Child Dev. 2013; 84 (Available at:): 121-132
- Detection of clinically relevant exonic copy-number changes by array CGH.Hum Mutat. 2010; 31 (Available at:): 1326-1342
- Copy number and SNP arrays in clinical diagnostics.Annu Rev Genomics Hum Genet. 2011; 12 (Available at:): 25-51
- If not Angelman, what is it? A review of Angelman-like syndromes.Am J Med Genet A. 2014; 164A (Available at:): 975-992
- Recent advances in assays for the fragile X-related disorders.Hum Genet. 2017; 136 (Available at:): 1313-1327
- Diagnostic utility of genome-wide DNA methylation testing in genetically unsolved individuals with suspected hereditary conditions.Am J Hum Genet. 2019; 104 (Available at:): 685-700
- Profiling DNA methylation based on next-generation sequencing approaches: new insights and clinical applications.Genes (Basel). 2018; 9 ([pii:E429]. Available at:)
- Characterization of intellectual disability and autism comorbidity through gene panel sequencing.Hum Mutat. 2019; 40 (Available at:): 1346-1363
- The sequence of the human genome.Science. 2001; 291 (Available at:): 1304-1351
- Exome sequencing: current and future perspectives.G3 (Bethesda). 2015; 5 (Available at:): 1543-1550
- Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders.Genet Med. 2019; 21 (Available at:): 2413-2421
- What is next generation sequencing?.Arch Dis Child. 2013; 98 (Available at:): 236-238
- The Exome Clinic and the role of medical genetics expertise in the interpretation of exome sequencing results.Genet Med. 2017; 19 (Available at:): 1040-1048
- Performance comparison of four commercial human whole-exome capture platforms.Sci Rep. 2015; 5 (Available at:): 12742
- Evaluation of the performance of copy number variant prediction tools for the detection of deletions from whole genome sequencing data.J Biomed Inform. 2019; 94 (Available at:): 103174
- Lack of diversity in genomic databases is a barrier to translating precision medicine research into practice.Health Aff (Millwood). 2018; 37 (Available at:): 780-785
- Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases.NPJ Genom Med. 2018; 3 (Available at:): 16
- Analysis of genomic variation in non-coding elements using population-scale sequencing data from the 1000 Genomes Project.Nucleic Acids Res. 2011; 39 (Available at:): 7058-7076
- Interpreting noncoding genetic variation in complex traits and human disease.Nat Biotechnol. 2012; 30 (Available at:): 1095-1106
- Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease.Nat Genet. 2003; 33 (Available at:): 228-237
- Integrative annotation of variants from 1092 humans: application to cancer genomics.Science. 2013; 342 (Available at:): 1235587
- Whole genome paired-end sequencing elucidates functional and phenotypic consequences of balanced chromosomal rearrangement in patients with developmental disorders.J Med Genet. 2019; 56 (Available at:): 526-535
- Balanced chromosomal rearrangement detection by low-pass whole-genome sequencing.Curr Protoc Hum Genet. 2018; 96 (Available at:): 8.18.1-8.18.16
- Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.Genet Med. 2015; 17 (Available at:): 689-701
- Evaluating heteroplasmic variations of the mitochondrial genome from whole genome sequencing data.Gene. 2019; 699 (Available at:): 145-154
- The third revolution in sequencing technology.Trends Genet. 2018; 34 (Available at:): 666-681
- The immune deficiency of chromosome 22q11.2 deletion syndrome.Am J Med Genet A. 2017; 173 (Available at:): 2366-2372
- A brother and sister with intellectual disability and characteristic neuroimaging findings.Eur J Paediatr Neurol. 2018; 22 (Available at:): 866-869
- Genetic mimics of cerebral palsy.Mov Disord. 2019; 34 (Available at:): 625-636
- Using facial analysis technology in a typical genetic clinic: experience from 30 individuals from a single institution.J Hum Genet. 2019; 64 (Available at:): 1243-1245
- Importance of pedigree in patients with familial epilepsy and intellectual disability.Sudan J Paediatr. 2019; 19 (Available at:): 52-56
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.Genet Med. 2015; 17 (Available at:): 405-424
- Is 'likely pathogenic' really 90% likely? Reclassification data in ClinVar.Genome Med. 2019; 11 (Available at:): 72
- A systemicatic approach to assessing the clinical significance of genetic variants.Clin Genet. 2013; 84 (Available at:): 453-463
- The known unknown: the challenges of genetic variants of uncertain significance in clinical practice.J Law Biosci. 2017; 4 (Available at:): 648-657
- Reporting practices for variants of uncertain significance from next generation sequencing technologies.Eur J Med Genet. 2017; 60 (Available at:): 553-558
- What does it mean?": uncertainties in understanding results of chromosomal microarray testing.Genet Med. 2012; 14 (Available at:): 250-258
- Molecular genetic testing and the future of clinical genomics.Nat Rev Genet. 2013; 14 (Available at:): 415-426
- Analysis of protein-coding genetic variation in 60,706 humans.Nature. 2016; 536 (Available at:): 285-291
- The mutational constraint spectrum quantified from variation in 141,456 humans.Nature. 2020; 581 (434-3. Available at: https://doi.org/10.1038/s41586-020-2308-7)
- ClinVar: improving access to variant interpretation and supporting evidence.Nucleic Acids Res. 2018; 46 (Available at:): D1062-D1067
- The Database of Genomic Variants: a curated collection of structural variation in the human genome.Nucleic Acids Res. 2014; 42 (Available at:): D986-D992
- DbVar and DGVa: public archives for genomic structural variation.Nucleic Acids Res. 2013; 41 (Available at:): 936-941
- Current use of chromosomal microarray by Australian paediatricians and implications for the implementation of next generation sequencing.J Paediatr Child Health. 2017; 53 (Available at:): 650-656
- Technical report: ethical and policy issues in genetic testing and screening of children.Genet Med. 2013; 15 (Available at:): 234-245
- Pediatric clinical exome/genome sequencing and the engagement process: encouraging active conversation with the older child and adolescent: points to consider - a statement of the American College of Medical Genetics and Genomics (ACMG).Genet Med. 2018; 20 (Available at:): 692-694
- Chromosomal microarrays: understanding genetics of neurodevelopmental disorders and congenital anomalies.J Pediatr Genet. 2017; 6 (Available at:): 42-50
- Diagnostic yield of next-generation sequencing applied to neurological disorders.J Clin Neurosci. 2019; 67 (Available at:): 14-18
- Whole exome sequencing in pediatric neurology patients: clinical implications and estimated cost analysis.J Child Neurol. 2016; 31 (Available at:): 887-894
- Regional models of genetic services in the United States.Genet Med. 2019; 22 (Available at:): 381-388
- Utilization of genetic testing among children with developmental disabilities in the United States.Appl Clin Genet. 2016; 9 (Available at:): 93-100
- Genetic testing experiences among parents of children with autism spectrum disorder in the United States.J Autism Dev Disord. 2019; 49 (Available at:): 4821-4833
- Variants of unknown significance on chromosomal microarray analysis: parental perspectives.J Community Genet. 2015; 6 (Available at:): 343-349
- Minerva consortium. enabling global clinical collaborations on identifiable patient data: the minerva initiative.Front Genet. 2019; 10 (Available at:): 611
- New and emerging medications for treatment of pediatric epilepsy.Pediatr Neurol. 2019; ([pii:S0887-8994(19)30923-3]. Available at:)https://doi.org/10.1016/j.pediatrneurol.2019.11.008
Article info
Publication history
Published online: July 03, 2020
Identification
Copyright
© 2020 Elsevier Inc. All rights reserved.
